Examining the relationship and clinical management between traumatic brain injury and pain in military and civilian populations - Mehalick ML, Glueck AC.
In this review, we discuss the comorbidity of traumatic brain injury (TBI) and pain among civilians and military members, the common causes of pain resulting from TBI, and offer insight about the therapeutic management of TBI symptoms and pain. Traumatic b... (Source: SafetyLit)
Source: SafetyLit - July 17, 2018 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Rheumatology in a Chronic Pain Multi-Disciplinary Team Rheumatology in a Chronic Pain Multi-Disciplinary Team
A rheumatologist could play an important role in the multidisciplinary team approach to the management of chronic lower back pain.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 17, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

FDA Drug Shortages Task Force Applauded by EMS Physicians
Last week the Food and Drug Administration announced the formation of a Drug Shortages Task Force aimed at alleviating nationwide shortages of life-saving drugs. The National Association of EMS Physicians (NAEMSP) and other medical groups representing physicians and medical professionals across the country are throwing their support behind the new FDA task force, which was created at the urging of Congress. The NAEMSP, an organization of more than 1,500 physicians and EMS professionals who advocate for all levels of EMS care providers, has been actively engaged on drug shortages issues in Washington since shortages of esse...
Source: JEMS Administration and Leadership - July 16, 2018 Category: Emergency Medicine Authors: JEMS Staff Tags: News Administration and Leadership Source Type: news

FDA Drug Shortages Task Force Applauded by EMS Physicians
Last week the Food and Drug Administration announced the formation of a Drug Shortages Task Force aimed at alleviating nationwide shortages of life-saving drugs. The National Association of EMS Physicians (NAEMSP) and other medical groups representing physicians and medical professionals across the country are throwing their support behind the new FDA task force, which was created at the urging of Congress. The NAEMSP, an organization of more than 1,500 physicians and EMS professionals who advocate for all levels of EMS care providers, has been actively engaged on drug shortages issues in Washington since shortages of esse...
Source: JEMS: Journal of Emergency Medical Services News - July 16, 2018 Category: Emergency Medicine Authors: JEMS Staff Tags: News Administration and Leadership Source Type: news

This Simple Trick Will Make You Happier and Better at Your Job
Tech startups are famous for installing nap pods and break rooms to attract Millennial workers. But most people work in offices where slipping off for a snooze or a foosball match would put a big dent in their promotion prospects. Even for self-employed or remote workers who don’t have a boss peering over their shoulder, taking anything more than a lunch break during work hours is anathema. But this “all work and no play” ethos may be harming employee health and productivity. The latest evidence suggests that taking short breaks during the work day makes employees happier and better at their jobs. A rece...
Source: TIME: Health - July 16, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthytime Mental Health/Psychology Source Type: news

Drilling down to the details of opioid signaling
Despite using opioids for centuries for pain management, we still don ’t have a complete understanding of how drugs like morphine and oxycodone actually work. And that’s a problem for patients, who must weather side effects that can range from nausea and constipation to cognitive impairment, addiction, and, at high doses, even death. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - July 11, 2018 Category: Universities & Medical Training Authors: Levi Gadye Source Type: news

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
In this cross-sectional study of 62 products used to treat low back pain examined across 50 Medicaid, Medicare Advantage, and commercial insurance plans, utilization management strategies were common for nonopioids and opioids alike. (Source: HSR Information Central)
Source: HSR Information Central - July 9, 2018 Category: International Medicine & Public Health Source Type: news

Consumed by Depression: Mental Illness and Its Pain
Pain is universal, varied, and subjective. An evolutionary deterrent and motivator, in some ways essential, in some ways utterly pointless. It can provide common ground, or be the most isolating of experiences. Everyone falls somewhere within its range. My pain came from depression. Not everyone experiences depression in this way; for some it may be a numbness, a complete absence of emotion. For me, it was active, physical. It began as a little ball of discomfort just below my rib cage, then spreads through my entire torso, eventually radiating outward into my limbs and stopping just short of my finger and toe nails. It fl...
Source: Psych Central - July 6, 2018 Category: Psychiatry Authors: Elspeth Roake Tags: Depression Personal Stories Self-Esteem Suicide Source Type: news

Unsealed lawsuit: Opioid firm placed profits over people
An unsealed lawsuit by Tennessee's attorney general says the maker of the world's top-selling painkiller directed its salesforce to target the highest prescribers, many with limited or no pain management background (Source: ABC News: Health)
Source: ABC News: Health - July 5, 2018 Category: Consumer Health News Tags: Health Source Type: news

First, We Need To Talk: Mental Healthcare In The MENA Region
The Middle East and North Africa (MENA) face daunting challenges in managing a growing burden of mental illness, often in adverse conditions that can leave their imprint on generations to come.While the burden of mental-health conditions is above the global average in most MENA countries, the human resources, policies, funding and infrastructure to deal with these problems are sorely lacking.According to a recent study led by the Institute for Health Metrics and Evaluation (IHME), mental disorders excluding substance abuse accounted for 4.7% of all disability-adjusted life years (DALYs) in the World Health Organization &rs...
Source: EyeForPharma - July 5, 2018 Category: Pharmaceuticals Authors: Marc Yates Source Type: news

The grass is not always greener: a multi-institutional pilot study of marijuana use and acute pain management following traumatic injury - Salottolo K, Peck L, Tanner Ii A, Carrick MM, Madayag R, McGuire E, Bar-Or D.
BACKGROUND: Widespread legislative efforts to legalize marijuana have increased the prevalence of marijuana use and abuse. The effects of marijuana on pain tolerance and analgesic pain management in the acute pain setting have not been reported. Although m... (Source: SafetyLit)
Source: SafetyLit - July 5, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

How a New Emphysema Device Won FDA Approval in Six Months
FDA has approved a new device intended to treat breathing difficulty associated with severe emphysema. The approval comes just two weeks after an FDA advisory panel shot down a competing technology targeting the same patient population. The agency approved Pulmonx Inc.'s Zephyr endobronchial valve through the breakthrough device designation, a pathway reserved for devices that provide for more effective treatment or diagnosis of a life-threatening or irreversibly debilitating disease or condition. Devices also must meet one of the following criteria: the device must represent a breakthrough technology; there must be no app...
Source: MDDI - July 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

June 2018 Briefing - Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Pulmonx wins FDA approval for Zephyr endobronchial valve
The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema. Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The Zephyr device is designed to decrease the volume of the chest to improve function in the heart, respiratory muscles and healthy lung tissue. Inserted via bronchoscopy, the pencil-eraser-sized valves prevent air from ent...
Source: Mass Device - June 29, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Pulmonx Source Type: news

Relievant Medsystems heads for Minnesota after $58m Series E
Relievant Medsystems said yesterday that it plans to move to Minnesota now that it’s closed on a $58 million Series E round. Led by Endeavour Vision, joined by new backer RK Mellon and existing investors New Enterprise Assoc., Canaan Ventures, Morgenthaler and Emergent Ventures, the round is earmarked for U.S. commercialization of Relievant’s Intracept intraosseous nerve ablation system for treating chronic lower back pain. Although it plans to maintain its R&D and operations facility in Sunnyvale, Calif., Relievant said it plans to move its HQ to Minneapolis. The cash infusion is also slated for a sec...
Source: Mass Device - June 27, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Neuromodulation/Neurostimulation Pain Management Wall Street Beat Relievant Medsystems Inc. Source Type: news

AcelRx receives European Commission approval for DZUVEO(TM)
AcelRx's DZUVEO receives EU approval for management of acute moderate to severe pain in medically monitored settings REDWOOD CITY, Calif., June 27, 2018 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx o... Biopharmaceuticals, Drug Delivery, Regulatory AcelRx Pharmaceuticals, DZUVEO, DSUVIA , sufentanil, sublingual (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

Training module now available for acute pain management in hospitalized adults
A case-based clinician training module designed for the evaluation of acute pain and opioid management for adults is now available through the Centers of Excellence in Pain Education (CoEPE) program, coordinated by the National Institute on Drug Abuse. Opioid Management for Acute Pain in... (Source: NIDA News)
Source: NIDA News - June 27, 2018 Category: Addiction Tags: Health and Medical Professionals, NIDAMED News, Pain, Researchers, Treatment Research, Prescription Drugs, Pain Medication, Opioids Source Type: news

Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Salix Sales Force to Begin Promoting LUCEMYRA to Primary Care and Pain Management Physicians LUCEMYRA is the First and Only Non-Opioid Medication Approved for Mitigation of Opioid Withdrawal Symptoms 08:00 ET from US WorldMeds LOUISVILLE, Ky. and... Biopharmaceuticals, Distribution US WorldMeds, Salix Pharmaceuticals, LUCEMYRA, lofexidine, Opioid Withdrawal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

Spine surgery patients less likely to be opioid dependent after surgery
(University of Louisville) Spine surgeons and researchers at UofL, concerned about potential opioid misuse resulting from pain management related to surgery, have discovered positive news in a study of back surgery patients. The study, conducted by researchers in the UofL Department of Neurological Surgery, concludes that patients undergoing surgery for degenerative spondylolisthesis are less likely to be dependent on opioids after than before the surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 26, 2018 Category: International Medicine & Public Health Source Type: news

Bridging the Healthcare Interoperability Gap
Interoperability has been a major challenge in healthcare since the early days of electronic medical records. A 2015 survey of nurses found that the lack of interoperability between medical devices and electronic health records is not only burdensome for them but can lead to dangerous medical errors. Some healthcare organizations have attempted to integrate their systems to streamline data, but doing so has been a slow, expensive process that is also difficult to maintain. Now, a startup company founded just last year, has developed an integration platform as a service intended to ease some of that pain for healthcare...
Source: MDDI - June 21, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news

Anika shares plummet after Phase III trial misses endpoint
Shares in Anika Therapeutics (NSDQ:ANIK) fell more than -30% this week after the company reported that its osteoarthritis drug, Cingal, failed in a Phase III trial. The therapy, designed to treat osteoarthritis of the knee, is a combination of cross-linked hyaluronic acid and triamcinolone hexacetonide. The trial’s primary endpoint compared the pain reduction experienced by patients treated with Cingal compared to those treated with just TH at 26 weeks. Get the full story at our sister site, Drug Delivery Business News. The post Anika shares plummet after Phase III trial misses endpoint appeared first on MassDev...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Pain Management Pharmaceuticals Wall Street Beat Anika Therapeutics Inc. Source Type: news

Local university receives grant to help fight opioid epidemic
As the growing opioid epidemic targets the Dayton area, a local university has received funding to help combat the crisis.   Cedarville University’s School of Pharmacy earned a $25,000 grant from the Cardinal Health Foundation’s Generation Rx Best Practices in Pain Medication Use grant program. The grant will help the university implement a chronic pain management program featuring an enhanced communication system . The program, a partnership between the university and the Springfield-based… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 21, 2018 Category: American Health Authors: Elizabeth Kyle Source Type: news

New Recommendations Guide Arthritis Pain Management
THURSDAY, June 21, 2018 -- The European League Against Rheumatism has released recommendations -- published in the June issue of the Annals of the Rheumatic Diseases -- for health professionals to use in approaching pain management in inflammatory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2018 Category: Pharmaceuticals Source Type: news

New Drugs Promise Hope This World Sickle Cell Day
This year brings a bit of good news regarding the drug pipeline for sickle cell disease, but pain management is a growing problem. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 19, 2018 Category: Pharmaceuticals Authors: Judy Stone, Contributor Source Type: news

Oligomerization of MrgC11 and {mu}-opioid receptors in sensory neurons enhances morphine analgesia
The μ-opioid receptor (MOR) agonist morphine is commonly used for pain management, but it has severe adverse effects and produces analgesic tolerance. Thus, alternative ways of stimulating MOR activity are needed. We found that MrgC11, a sensory neuron–specific G protein–coupled receptor, may form heteromeric complexes with MOR. Peptide-mediated activation of MrgC11 enhanced MOR recycling by inducing coendocytosis and sorting of MOR for membrane reinsertion. MrgC11 activation also inhibited the coupling of MOR to β-arrestin-2 and enhanced the morphine-dependent inhibition of cAMP production. Intrathecal...
Source: Signal Transduction Knowledge Environment - June 19, 2018 Category: Science Authors: He, S.-Q., Xu, Q., Tiwari, V., Yang, F., Anderson, M., Chen, Z., Grenald, S. A., Raja, S. N., Dong, X., Guan, Y. Tags: STKE Research Articles Source Type: news

Low Back Pain: Should We Recommend Chiropractic Care? Low Back Pain: Should We Recommend Chiropractic Care?
A study looked at adding spinal manipulation and other chiropractic care to the overall management of low back pain.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 18, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

World Continence Week
2018 is held between 18-24 June and is a global initiative run by theWorld Federation of Incontinence Patients (WFIP), with the approval of theInternational Continence Society (ICS). The vision is to help improve health, wellness and quality of life for those with continence issues, and to further establish awareness of bladder weakness, pelvic pain and other conditions that impact on the lives of patients and carers.Cochrane Incontinence works with authors to prepare, maintain and disseminate systematic reviews of the effectiveness of interventions for incontinence, including prevention, treatment and rehabilitation. The...
Source: Cochrane News and Events - June 18, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Understanding the Benefits of Acupuncture Treatment for Cancer Pain Management
This article reviews how acupuncture is thought to work, data on acupuncture for managing pain caused by cancer or by cancer treatment, how acupuncture is practiced in the US medical system, discussion of safety issues, and practical tips on how to integrate acupuncture into cancer care. (Source: CancerNetwork)
Source: CancerNetwork - June 15, 2018 Category: Cancer & Oncology Authors: Gary Deng, MD, PhD, Ting Bao, MD, Jun J. Mao, MD, MSCE Source Type: news

NSAIDs Increase Cardiovascular Risk in Osteoarthritis NSAIDs Increase Cardiovascular Risk in Osteoarthritis
Nonsteroidal anti-inflammatory drugs contribute to the elevated risk for cardiovascular disease in people with osteoarthritis, new research shows, but alternatives for pain management are limited.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

FDA approves first generic sublingual film to treat opioid addiction
The FDA this week approved the first generic version of Indivior‘s (LON:INDV) billion-dollar opioid addiction treatment, Suboxone. The generic buprenorphine and naloxone sublingual film, sold by Dr. Reddy’s Laboratories (NYSE:RDY) and Mylan (NSDQ:MYL), is designed to suppress withdrawal symptoms that crop in people addicted to opioids, as well as block the neurochemical effects of opioids. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves first generic sublingual film to treat opioid addiction appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Dr. Reddy's Laboratories indivior Mylan Source Type: news

First-Ever Ketamine Guidelines for Pain Management Released First-Ever Ketamine Guidelines for Pain Management Released
Consensus guidelines provide a framework for use of IV ketamine for acute pain management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

First-Ever Ketamine Guidelines for Acute Pain Management Released First-Ever Ketamine Guidelines for Acute Pain Management Released
Consensus guidelines provide a framework for use of IV ketamine for acute pain management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Advance Care Planning for Pain Management in Dementia Advance Care Planning for Pain Management in Dementia
Pain is often under-treated in older patients with dementia. How might pain management be incorporated into advanced care planning, and what are the challenges?The Gerontologist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

NIH Outlines New Game Plan to Combat Opioid Crisis NIH Outlines New Game Plan to Combat Opioid Crisis
The HEAL initiative will focus on improving treatments for patients who misuse or are addicted to opioids and enhancing strategies for effective pain management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Managing Cancer Pain in the Era of an Opioid Crisis Managing Cancer Pain in the Era of an Opioid Crisis
An expert panel discussed management and strategies for caring for patients and avoiding misuse of opioids, and also touched on growing concerns of limited access.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pain Management Over-The-Counter
Title: Pain Management Over-The-CounterCategory: Doctor's& Expert's views on SymptomsCreated: 9/5/2000 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:08 PM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - June 13, 2018 Category: Anesthesiology Source Type: news

Study finds music therapy brings effective pain relief for sickle cell patients
(University Hospitals Cleveland Medical Center) In a randomized controlled trial, patients with sickle cell disease were assigned to one of three 20-minute conditions: a session with a music therapist, an iPod to listen to pre-selected music themselves, or no music at all. While passively listening to music improved mood, music therapy had a significantly stronger impact on aiding in pain management for patients actively engaged with a music therapist. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2018 Category: Cancer & Oncology Source Type: news

Teardown: Inside the Neurometrix Quell TENS device
A TENS device for transcutaneous electrical nerve stimulation wraps around the upper calf much like a wristwatch wraps around the wrist. Here are some of its operational secrets. By Lee Teschler A medical device called a Quell performs what’s called transcutaneous electrical nerve stimulation on the lower leg. This technique is said to relieve diabetic pain. None of us here are diabetic so we can’t say whether the Quell actually does what its manufacturer — Neurometrix Inc. of Waltham, Mass. — claims it can do. What we can do is describe how the Quell is supposed to work and what we found...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: MassDevice Tags: Neuromodulation/Neurostimulation Pain Management Neurometrix Source Type: news

NIH Unveils New Opioid Research Plans
(MedPage Today) -- HEAL initiative seeks to combat addiction, improve pain management (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - June 12, 2018 Category: Neurology Source Type: news

NIH initiative aims to tackle opioid misuse, addiction, enhance pain management
(JAMA Network) In the   JAMA Viewpoint, 'Helping to End Addiction Over the Long-Term: The Research Plan for the NIH HEAL Initiative,' National Institutes of Health Director   Francis S. Collins, M.D., Ph.D., and coauthors discuss an interdisciplinary program aimed at advancing addiction and pain research in the United States to improve treatments for opioid misuse and addiction and to enhance pain management. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 12, 2018 Category: International Medicine & Public Health Source Type: news

NIH leadership outlines interdisciplinary FY2018 research plan for HEAL Initiative
The plan focuses on improving treatments for opioid misuse and addiction, and enhancing strategies for pain management. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 11, 2018 Category: American Health Source Type: news

Mass. Researchers May Be On Brink Of Creating Revolutionary, Non-Addictive Painkiller
CAMBRIDGE (CBS NEWS) — Researchers in Massachusetts believe they may be on the brink of creating a revolutionary non-addictive painkiller. Developed by Blue Therapeutics, Blue-181 could be a big step forward in dealing with the growing opioid crisis. The team there said it wanted to make a drug that is a total replacement for the opioids currently on the market – something that people could safely stop using without the possible dangerous side effects. Mark Loccisano felt a gratification from painkillers with his very first pill. They were prescribed by a doctor for a sports injury. It was the beginning of an o...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 8, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Cambridge Local TV opioid crisis Source Type: news

Halyard Health inks $65m deal to acquire CoolSystems
Halyard Health (NYSE:HYH) said today it inked a $65 million deal to acquire cold and compression therapy company CoolSystems, which markets under the name Game Ready. CoolSystems produces devices designed for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries, including its GRPro 2.1 cold and compression therapy system, Med4 Elite multi-modality therapy unit and ATX wraps. Alpharetta, Ga.-based Halyard said the products acquired with the company will complement its existing pain management portfolio. “The acquisition of Game Ready represents another step ...
Source: Mass Device - June 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Pain Management Avanos Medical (formerly Halyard Health) Source Type: news

Halyard Health Announces Agreement to Acquire CoolSystems, Inc., Marketed as Game Ready(R)
Game Ready's pain management and rehabilitation therapies enhance and diversify Halyard's non-opioid Pain Management portfolio Transaction expands Halyard's call point footprint, increasing access within the orthopedic and sports medicine markets and cr... Devices, Orthopaedic, Mergers & Acquisitions Halyard Health, CoolSystems, Game Ready, cold therapy, compression therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

’ 13 Reasons Why ’ : Critique by a Recovered Depressive
I almost had the same fate as Hannah Baker. After having teetered so close to the edge of death, I am surprised a lot of days that I am actually still alive, that I didn’t perish in the bathtub when I dropped the hairdryer into the water. I finished watching the second season of 13 Reasons Why last night, and this show has stirred up a storm of thoughts and emotions for me, given my experience, so I thought I might contribute to the conversation that this show is igniting.  I first started having suicidal thoughts when I was a junior in high school. As I drove home from school, I often thought about swerving in...
Source: Psych Central - June 4, 2018 Category: Psychiatry Authors: Kristen Davis Tags: Children and Teens Depression Essays Genetics Neuroscience Personal Stories Students Suicide 13 Reasons Why Adolescence Depressive Episode Media Depictions Teen Depression Teen Suicide Source Type: news

Will Medtech Rise to FDA & #039;s Challenge in the War on Opioid Abuse?
It isn't the first time FDA has turned to medtech for solutions to opioid misuse and abuse, but now the agency is officially challenging the medical device and diagnostics industry to step up in the ongoing war on opioids. FDA recently launched an innovation challenge to spur the development of devices, digital health technologies, and diagnostic tests that could provide novel solutions in response to the opioid epidemic. That's not to say the industry hasn't already put forth some effort in this area. Manufacturers of naloxone products – a drug designed to potentially save a person's life in the event of an opioid o...
Source: MDDI - June 1, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Digital Health Source Type: news

Halyard Health to rebrand as Avanos Medical
Halyard Health (NYSE:HYH) said today that it’s planning to re-brand – and re-list its stock – under the Avanos Medical name. Alpharetta, Ga.-based Halyard, formed by the November 2014 spinout of Kimberly-Clark (NYSE:KMB) unit K-C Health Care, said it derived its new moniker from the words “advanced” and “innovation” to emphasize its “focus on innovating with speed to deliver better, more sustainable patient outcomes.” A month ago, Halyard closed the $710 million sale of its surgical and infection prevention business to Owens & Minor (NYSE:OM...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Pain Management Wall Street Beat Avanos Medical (formerly Halyard Health) Source Type: news

Survey: Most Oncologists Discuss Medical Marijuana with Cancer Patients
Medical marijuana continues to be a hot topic among mesothelioma patients and a popular way to cope with disease symptoms and treatment side effects. As more states legalize marijuana for medicinal purposes, more cancer patients are asking their doctors about the natural therapy. A recent survey published in the Journal of Clinical Oncology shows as many as 80 percent of oncologists talk about medical marijuana with their patients. Of the 237 oncologists who responded to the survey, more than half (55 percent) practice in one of the 28 states where medical marijuana is legal. Questions on the survey covered recommendations...
Source: Asbestos and Mesothelioma News - June 1, 2018 Category: Environmental Health Authors: Daniel King Source Type: news